Evidence from our meta-analysis suggests that AhR rs2066853 polymorphism is not a risk factor for cancer either in the overall population, Caucasians, Asians, or Chinese, and this polymorphism is not a risk factor for lung cancer or breast cancer. Here, AHR is linked to breast carcinoma.